{"product_id":"anabolex-business-model-canvas","title":"Anaborex, Inc. Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAnaborex's Business Model Unveiled!\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eExplore the core components of Anaborex, Inc.'s strategic framework with our comprehensive Business Model Canvas. This document details their key customer segments, unique value propositions, and revenue streams, offering a clear view of their operational engine. Ready to understand what truly drives Anaborex's success and how you can apply similar principles to your own ventures? \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Pharmaceutical Collaborations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAnaborex, Inc. will forge co-development and licensing agreements with major pharmaceutical players. These collaborations are vital for shouldering the immense financial burden and inherent risks of late-stage clinical trials and bringing novel oncology and rare disease therapies to market.\u003c\/p\u003e\n\u003cp\u003eThese strategic alliances will grant Anaborex access to substantial resources, specialized knowledge, and established market channels. This significantly speeds up the process of getting life-changing treatments to patients who need them.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eContract Research Organizations (CROs)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAnaborex, Inc. relies on Contract Research Organizations (CROs) to manage its clinical trials, ensuring both efficiency and adherence to regulations for its innovative therapies. These specialized partners are crucial for navigating the complexities of drug development, from initial trial design and patient enrollment to meticulous data handling and final regulatory submissions.\u003c\/p\u003e\n\u003cp\u003eThe global CRO market is experiencing robust growth, projected to reach approximately $95 billion by 2027, highlighting the increasing demand for their specialized expertise. This expansion is fueled by the rising complexity of clinical trials, particularly those focused on personalized medicine and novel therapeutic approaches, areas where Anaborex operates.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAcademic and Research Institutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAnaborex, Inc. actively collaborates with top-tier academic and research institutions to drive groundbreaking scientific discoveries and advance preclinical development. These strategic alliances are crucial for accessing specialized research infrastructure, state-of-the-art technologies, and a continuous influx of brilliant scientific minds.\u003c\/p\u003e\n\u003cp\u003eFor instance, Anaborex's partnership with the University of California, San Francisco's Gladstone Institutes has been instrumental in their work on novel therapeutic targets. In 2024, such academic collaborations have been shown to accelerate drug discovery timelines by an average of 15% compared to internal efforts alone, according to industry reports.\u003c\/p\u003e\n\u003cp\u003eEngaging with these centers of learning not only validates Anaborex's innovative therapeutic strategies but also ensures the company remains at the vanguard of biotechnological progress, fostering a dynamic environment for innovation.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTechnology and AI Solution Providers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eAnaborex, Inc. strategically partners with technology and AI solution providers to accelerate its drug discovery and development. These collaborations are crucial for leveraging cutting-edge advancements in artificial intelligence and data analytics. For instance, AI platforms can analyze vast biological datasets, identifying potential drug targets and predicting compound efficacy at speeds unattainable through traditional methods. This integration streamlines the R\u0026amp;D pipeline, moving promising candidates from discovery to preclinical stages more efficiently.\u003c\/p\u003e\n\u003cp\u003eThe impact of AI on drug discovery is substantial, with a significant portion of pharmaceutical companies actively investing in AI technologies. By 2024, it's estimated that AI will play a role in over 75% of pharmaceutical R\u0026amp;D projects. These partnerships allow Anaborex to harness AI for: \u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\u003cstrong\u003eAccelerated identification of novel drug candidates.\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eOptimization of preclinical and clinical trial design.\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eEnhanced predictive modeling for drug safety and efficacy.\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eStreamlined data analysis from complex biological experiments.\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePatient Advocacy Groups and Foundations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eAnaborex, Inc. recognizes the critical role of patient advocacy groups and foundations in understanding patient needs and ensuring its therapies address real-world challenges. These partnerships are essential for gaining deep insights into the patient journey and for effective patient recruitment in clinical trials.\u003c\/p\u003e\n\u003cp\u003eCollaborating with organizations like the American Cancer Society, which reported supporting over 2 million cancer patients in 2023, and the Cancer Support Community, a global network providing free support to those affected by cancer, allows Anaborex to align its development efforts with the most pressing patient requirements.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eUnderstanding Patient Needs:\u003c\/strong\u003e Advocacy groups offer direct feedback on the impact of conditions like cancer wasting syndrome, guiding Anaborex's research and development priorities.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFacilitating Clinical Trials:\u003c\/strong\u003e These partnerships are crucial for patient outreach and recruitment, accelerating the pace of clinical trials and bringing treatments to market faster. In 2024, the average cancer clinical trial enrollment faced delays, highlighting the importance of these relationships.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRaising Awareness and Support:\u003c\/strong\u003e Collaborations help in educating the public and healthcare providers about Anaborex's innovative solutions, fostering broader adoption and support for its therapies.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Alliances Powering Drug Development\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAnaborex's key partnerships are essential for navigating the complex landscape of drug development and market entry.\u003c\/p\u003e\n\u003cp\u003eThese include co-development and licensing agreements with major pharmaceutical companies to share costs and risks of late-stage trials, and collaborations with Contract Research Organizations (CROs) to manage clinical trials efficiently and compliantly.\u003c\/p\u003e\n\u003cp\u003eFurthermore, Anaborex leverages partnerships with academic institutions for scientific discovery and with technology\/AI providers to accelerate R\u0026amp;D, alongside engaging patient advocacy groups to ensure therapies meet patient needs and facilitate trial recruitment.\u003c\/p\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eThis Anaborex, Inc. Business Model Canvas provides a strategic blueprint, detailing target customer segments, primary revenue streams, and unique value propositions to drive growth in the pharmaceutical sector.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eAnaborex, Inc.'s Business Model Canvas offers a streamlined approach to identifying and addressing critical market gaps, acting as a pain point reliever by clearly outlining value propositions and customer segments.\u003c\/p\u003e\n\u003cp\u003eThis concise, one-page snapshot allows for rapid assessment of how Anaborex, Inc. effectively targets and resolves customer frustrations, making it ideal for quick strategic reviews.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eNovel Therapy Research and Development\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAnaborex, Inc.'s core activity is the rigorous research and development of groundbreaking biotechnological therapies aimed at combating wasting syndrome, especially in individuals battling cancer. This encompasses crucial stages like identifying therapeutic targets, refining promising drug candidates, and conducting preclinical trials to confirm both effectiveness and safety.\u003c\/p\u003e\n\u003cp\u003eThe company's efforts are squarely focused on meeting the substantial unmet medical demand for treatments that can effectively manage cancer cachexia. For instance, in 2024, the global market for cancer cachexia treatments was projected to reach approximately $2.5 billion, highlighting the critical need Anaborex aims to fill.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClinical Trial Management and Execution\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAnaborex's core operations revolve around the meticulous planning, execution, and ongoing monitoring of clinical trials for its innovative drug candidates. This crucial phase ensures the safety and efficacy of potential treatments.\u003c\/p\u003e\n\u003cp\u003eKey activities include strategic patient recruitment, robust data collection across all trial phases, and unwavering adherence to strict regulatory guidelines set forth by bodies like the FDA. For instance, in 2024, the average cost to conduct a Phase III clinical trial for a new drug can range from $30 million to $70 million, highlighting the significant investment required.\u003c\/p\u003e\n\u003cp\u003eSuccessful clinical trial management is absolutely essential for Anaborex to navigate the complex drug development pathway, ultimately aiming for regulatory approval and market availability of its therapies.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory Affairs and Compliance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAnaborex, Inc. dedicates significant resources to navigating the intricate regulatory pathways crucial for biotechnology and pharmaceutical advancement. This involves meticulous preparation and submission of vital documents such as Investigational New Drug (IND) applications and New Drug Applications (NDA) to health authorities worldwide.\u003c\/p\u003e\n\u003cp\u003eStaying current with evolving regulatory mandates, particularly those impacting novel therapeutic modalities and the integration of artificial intelligence in drug discovery, is a paramount and ongoing activity. For instance, in 2024, the FDA continued to refine its framework for AI\/ML-based medical devices, a development Anaborex actively monitors to ensure compliance in its AI-driven research initiatives.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClinical Research Services for Metabolic Diseases\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eAnaborex, Inc. extends its metabolic disease expertise by offering specialized clinical research services to external clients. This strategic move taps into the growing demand for outsourced clinical trial management within the pharmaceutical and biotechnology sectors. The company's proficiency in metabolic disease research allows it to provide valuable support to other organizations seeking to advance their own therapeutic candidates.\u003c\/p\u003e\n\u003cp\u003eThese services encompass the full spectrum of clinical study execution, including protocol design, patient recruitment and retention, data management, and statistical analysis. By leveraging its established infrastructure and experienced scientific team, Anaborex aims to streamline the development process for its partners. For instance, in 2024, the global clinical trials market was valued at approximately $25 billion, with a significant portion dedicated to specialized therapeutic areas like metabolic diseases.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eRevenue Diversification:\u003c\/strong\u003e Clinical research services represent a key revenue stream beyond Anaborex's proprietary drug pipeline, offering financial stability.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eLeveraging Core Competencies:\u003c\/strong\u003e The company capitalizes on its deep understanding and infrastructure in metabolic disease research to serve external clients.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMarket Demand:\u003c\/strong\u003e The outsourcing trend in clinical research, particularly for complex disease areas, creates a robust market opportunity for Anaborex's services.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIndustry Collaboration:\u003c\/strong\u003e This activity fosters valuable partnerships within the broader pharmaceutical and biotech ecosystem, potentially leading to future collaborations.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIntellectual Property Strategy and Management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eAnaborex, Inc. actively safeguards its groundbreaking therapies and research techniques through a comprehensive intellectual property (IP) strategy. This involves a continuous process of patent applications for novel drug candidates and manufacturing methods, alongside trademark registrations for its brand identity.  The company meticulously manages its growing portfolio of proprietary technologies, ensuring a strong foundation for future development and market exclusivity.\u003c\/p\u003e\n\u003cp\u003eA robust IP portfolio is paramount for Anaborex’s competitive edge in the dynamic biotech landscape.  For instance, in 2024, the biotechnology sector saw significant investment driven by strong patent protection, with companies holding key patents often commanding higher valuations.  Anaborex’s commitment to this area directly supports its ability to attract crucial funding and partnerships necessary for advancing its pipeline.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003ePatent Filings:\u003c\/strong\u003e Continuously submitting patent applications for new drug discoveries and innovative delivery systems.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTrademark Registrations:\u003c\/strong\u003e Securing brand names and logos associated with its therapeutic products and research platforms.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePortfolio Management:\u003c\/strong\u003e Strategically overseeing and expanding its collection of proprietary technologies and trade secrets.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCompetitive Advantage:\u003c\/strong\u003e Leveraging IP to deter competitors and establish market leadership for its novel treatments.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDriving Therapeutic Innovation: Research, Trials, and Strategic Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAnaborex's key activities are centered on pioneering research and development of therapies for wasting syndrome, meticulously managing clinical trials, and navigating complex regulatory landscapes. These efforts are supported by a robust intellectual property strategy to protect its innovations. Furthermore, the company diversifies its revenue and leverages its expertise by offering specialized clinical research services to external partners.\u003c\/p\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003ePreview Before You Purchase\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe Anaborex, Inc. Business Model Canvas preview you are viewing is the identical document you will receive upon purchase. This means the structure, content, and formatting are exactly as you see them, ensuring no surprises and immediate usability. You will gain full access to this comprehensive canvas, ready for your strategic planning needs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":55611361984889,"sku":"anabolex-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/anabolex-business-model-canvas.png?v=1754756106","url":"https:\/\/growthsharematrix.com\/products\/anabolex-business-model-canvas","provider":"Growth Share Matrix","version":"1.0","type":"link"}